ERBB2 and breast cancer: Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are recommended for HER2 testing in breast cancers as per the guidelines from the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) and Breast Cancer Expert Panel of China (4, 5).